Agostino Tafuri

Agostino Tafuri

UNVERIFIED PROFILE

Are you Agostino Tafuri?   Register this Author

Register author
Agostino Tafuri

Agostino Tafuri

Publications by authors named "Agostino Tafuri"

Are you Agostino Tafuri?   Register this Author

66Publications

1751Reads

44Profile Views

Metabolic Reprogramming Promotes Myogenesis During Aging.

Front Physiol 2019 10;10:897. Epub 2019 Jul 10.

Department of Orthopaedics and Traumatology, Hospital "Maggiore della Carità", Università del Piemonte Orientale (UPO), Novara, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fphys.2019.00897DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636331PMC
July 2019

Aggressive lymphomas of the elderly: the DEVEC metronomic chemotherapy schedule fits the unfit.

Br J Haematol 2018 12 28;183(5):819-822. Epub 2017 Nov 28.

Haematology unit, Azienda Ospedaliera Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15039DOI Listing
December 2018

Serum Free Light Chains Removal by HFR Hemodiafiltration in Patients with Multiple Myeloma and Acute Kidney Injury: a Case Series.

Kidney Blood Press Res 2018 3;43(4):1263-1272. Epub 2018 Aug 3.

Division of Nephrology, Dept. of Clinical and Molecular Medicine, Sant'Andrea University Hospital, "Sapienza" University of Rome, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000492408DOI Listing
November 2018

Biological Aspects of mTOR in Leukemia.

Int J Mol Sci 2018 Aug 14;19(8). Epub 2018 Aug 14.

Laboratory of Cell Kinetics and Applied Proteomics, Faculty of Medicine and Psychology, Department of Clinic and Molecular Medicine, Sapienza University of Rome, via Rovigo 1, 00161 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms19082396DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121663PMC
August 2018

Targeting the Akt, GSK-3, Bcl-2 axis in acute myeloid leukemia.

Adv Biol Regul 2017 08 19;65:36-58. Epub 2017 May 19.

Hematology, "Sant'Andrea" Hospital-Sapienza, University of Rome, Department of Clinical and Molecular Medicine, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbior.2017.05.002DOI Listing
August 2017

Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia.

Expert Opin Ther Targets 2017 07 9;21(7):705-714. Epub 2017 Jun 9.

b Section of Molecular Hematology and Therapy, Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14728222.2017.1333600DOI Listing
July 2017

The Calreticulin control of human stress erythropoiesis is impaired by JAK2V617F in polycythemia vera.

Exp Hematol 2017 06 21;50:53-76. Epub 2017 Feb 21.

Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Biomedical and Neuromotorial Sciences, Alma Mater University, Bologna, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2017.02.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779852PMC
June 2017

The tissue inhibitor of metalloproteinases 1 increases the clonogenic efficiency of human hematopoietic progenitor cells through CD63/PI3K/Akt signaling.

Exp Hematol 2015 Nov 23;43(11):974-985.e1. Epub 2015 Jul 23.

Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology L. and A. Seràgnoli, University of Bologna, Bologna, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2015.07.003DOI Listing
November 2015

Chronic phase chronic myeloid leukemia patients who failed interferon alpha and switched to imatinib: Long-term 9-year follow-up of 134 patients.

Am J Hematol 2015 May 30;90(5):E95-6. Epub 2015 Mar 30.

Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23972DOI Listing
May 2015

Emerging MEK inhibitors.

Expert Opin Emerg Drugs 2010 Jun;15(2):203-23

Brody School of Medicine at East Carolina University, Department of Microbiology & Immunology, 600 Moye Boulevard, Greenville, NC 27858, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/1472821090328276
Publisher Site
http://dx.doi.org/10.1517/14728210903282760DOI Listing
June 2010

Emerging Raf inhibitors.

Expert Opin Emerg Drugs 2009 Dec;14(4):633-48

Department of Microbiology & Immunology, Brody School of Medicine at East Carolina University, Greenville, NC 27858, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14728210903232633DOI Listing
December 2009

Activity of the BH3 mimetic ABT-737 on polycythemia vera erythroid precursor cells.

Blood 2009 Feb 5;113(7):1522-5. Epub 2008 Dec 5.

Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2008-03-143321DOI Listing
February 2009

Targeting the Raf/MEK/ERK pathway with small-molecule inhibitors.

Curr Opin Investig Drugs 2008 Jun;9(6):614-30

Brody School of Medicine at East Carolina University, Department of Microbiology & Immunology, 600 Moye Boulevard, Greenville, NC 27858, USA.

View Article

Download full-text PDF

Source
June 2008

Circulating myeloid dendritic cell directly isolated from patients with chronic myelogenous leukemia are functional and carry the bcr-abl translocation.

Leuk Res 2006 Jul 9;30(7):785-94. Epub 2006 Mar 9.

Dipartimento di Biotecnologie Cellulari ed Ematologia, University "La Sapienza", Via Benevento 6, 00161 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2005.11.028DOI Listing
July 2006

Increased death receptor resistance and FLIPshort expression in polycythemia vera erythroid precursor cells.

Blood 2006 May 29;107(9):3495-502. Epub 2005 Dec 29.

Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2005-07-30
Publisher Site
http://dx.doi.org/10.1182/blood-2005-07-3037DOI Listing
May 2006

Trisomy 13 in a patient with common acute lymphoblastic leukemia: description of a case and review of the literature.

Cancer Genet Cytogenet 2003 Jul;144(1):69-72

Dipartimento di Biotecnologie Cellulari ed Ematologia, University La Sapienza, Via Benevento 6, 00161 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0165-4608(02)00924-xDOI Listing
July 2003

Effects of IL-6 variants in multiple myeloma: growth inhibition and induction of apoptosis in primary cells.

Leuk Lymphoma 2002 Dec;43(12):2369-75

Dipartimento di Biotecnologie Cellulari ed Ematologia, Università La Sapienza, Via Benevento 6, 00161 Roma, Italy.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1080/1042819021000040
Publisher Site
http://dx.doi.org/10.1080/1042819021000040224DOI Listing
December 2002

Interleukin-11 induces proliferation of human T-cells and its activity is associated with downregulation of p27(kip1).

Haematologica 2002 Apr;87(4):373-80

Institute of Hematology and Medical Oncology Lorenzo & Ariosto Seràgnoli , University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
April 2002